Benzinga's Top Initiations

Nomura initiated coverage on
Colony Starwood Homes SFR
with a Buy rating. The target price for Colony Starwood Homes is set to $29. Colony Starwood Homes shares closed at $21.52 on Friday. Analysts at H.C. Wainwright initiated coverage on
VolitionRX Ltd VNRX
with a Buy rating. The target price for VolitionRX is set to $12. VolitionRX shares closed at $3.77 on Friday. Analysts at KeyBanc initiated coverage of
Acadia Healthcare Company IncACHC
with a Overweight rating. The target price for Acadia Healthcare is set to $85. Acadia Healthcare shares closed at $61.03 on Friday. Analysts at Credit Suisse initiated coverage on
LINDBLAD EXPEDITIONS HLDGS INCLIND
with a Outperform rating. The target price for Lindblad Expeditions Holdings is set to $14. Lindblad Expeditions Holdings shares closed at $10.02 on Friday. Canaccord Genuity initiated coverage of
Halozyme Therapeutics, Inc. HALO
with a Buy rating. Halozyme Therapeutics shares closed at $8.80 on Friday. Analysts at Nomura initiated coverage on
Altisource Residential CorpRESI
with a Neutral rating. The target price for Altisource Residential is set to $11. Altisource Residential shares closed at $9.95 on Friday. Analysts at H.C. Wainwright initiated coverage on
Eyegate Pharmaceuticals IncEYEG
with a Buy rating. The target price for Eyegate Pharmaceuticals is set to $10. Eyegate Pharmaceuticals shares closed at $1.70 on Friday. Chardan Capital initiated coverage on
Skyworks Solutions IncSWKS
with a Buy rating. The target price for Skyworks Solutions is set to $100. Skyworks Solutions shares closed at $68.92 on Friday. Canaccord Genuity initiated coverage on
Summit Therapeutics PLC (ADR) SMMT
with a Buy rating. Summit Therapeutics shares closed at $8.52 on Friday. Analysts at Northland Securities initiated coverage on
Fortinet Inc FTNT
with a Outperform rating. Fortinet shares closed at $28.14 on Friday.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Comments
Loading...